Clinical Study
Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study
Table 1
Demographic characteristics of the patients.
| | Rebamipide group ( = 82) | Untreated group ( = 87) | value |
| Mean age (range) | 57.7 ± 1.5 (22–85) | 56.7 ± 1.4 (27–80) | 0.6138 | Gender (male/female) | 42/40 | 36/51 | 0.1997 | Endoscopic diagnosis | Gastric ulcer, 13 Atrophic gastritis, 64 Early GC after ESD, 5 | Gastric ulcer, 4 Atrophic gastritis, 80 Early GC after ESD, 3 | 0.0317 | Alcohol (yes/no) | 31/40 (unknown, 11) | 23/55 (unknown, 9) | 0.0722 | Smoking (yes/no) | 11/59 (unknown, 12) | 8/69 (unknown, 10) | 0.3365 | Past history (yes/no) | 15/36 (unknown, 31) | 17/32 (unknown, 38) | 0.5714 |
|
|
Data are presented as mean ± standard error or as . GC: gastric cancer and ESD: endoscopic submucosal dissection.
|